Current Pharmaceutical Design, ISSN 1381-6128, 2011, Volume 17, Issue 26, pp. 2829 - 2842
Some of the ATP-binding cassette (ABC) transporters like P-glycoprotein (P-gp; ABCB1, MDR1), BCRP (ABCG2) and MRPs (ABCCs) that are present at the blood-brain...
P-glycoprotein | Addiction | Blood-brain barrier | Opioids | SLC transporters | Tolerance | Morphine | ABC transporters | Drugs of abuse | MULTIDRUG TRANSPORTER | MORPHINE TRANSPORT | DRUG-INTERACTIONS | addiction | HUMAN LIVER-MICROSOMES | P-GLYCOPROTEIN ABCB1 | morphine | drugs of abuse | INTESTINAL-ABSORPTION | EFFLUX TRANSPORTERS | IN-VIVO | PHARMACOLOGY & PHARMACY | CENTRAL-NERVOUS-SYSTEM | tolerance | opioids | CANCER RESISTANCE PROTEIN | Animals | Central Nervous System - metabolism | Biological Transport | Cytokines - metabolism | Humans | Analgesics, Opioid - pharmacokinetics | Neurotransmitter Agents - metabolism | ATP-Binding Cassette Transporters - metabolism | Analgesics, Opioid - pharmacology | Central Nervous System - drug effects | Blood-Brain Barrier - metabolism
P-glycoprotein | Addiction | Blood-brain barrier | Opioids | SLC transporters | Tolerance | Morphine | ABC transporters | Drugs of abuse | MULTIDRUG TRANSPORTER | MORPHINE TRANSPORT | DRUG-INTERACTIONS | addiction | HUMAN LIVER-MICROSOMES | P-GLYCOPROTEIN ABCB1 | morphine | drugs of abuse | INTESTINAL-ABSORPTION | EFFLUX TRANSPORTERS | IN-VIVO | PHARMACOLOGY & PHARMACY | CENTRAL-NERVOUS-SYSTEM | tolerance | opioids | CANCER RESISTANCE PROTEIN | Animals | Central Nervous System - metabolism | Biological Transport | Cytokines - metabolism | Humans | Analgesics, Opioid - pharmacokinetics | Neurotransmitter Agents - metabolism | ATP-Binding Cassette Transporters - metabolism | Analgesics, Opioid - pharmacology | Central Nervous System - drug effects | Blood-Brain Barrier - metabolism
Journal Article
Toxicological Sciences, ISSN 1096-6080, 2013, Volume 136, Issue 2, pp. 382 - 391
Endocrine-disrupting chemicals (EDCs) are considered to cause testicular toxicity primarily via interference with steroid hormone function. Alternatively, EDCs...
Endocrine disrupting chemicals (EDCs) | ABC transporters | Steroidogenesis | Blood-testis barrier | MA-10 mouse Leydig cells | steroidogenesis | TETRABROMOBISPHENOL-A | RATS | IDENTIFICATION | P-GLYCOPROTEIN | endocrine disrupting chemicals (EDCs) | INHIBITION | EFFLUX | blood-testis barrier | BROMINATED FLAME RETARDANTS | BISPHENOL-A | TOXICOLOGY | EXPRESSION | XENOGRAFTS | Testosterone - secretion | Humans | Cells, Cultured | Male | Leydig Cells - drug effects | Endocrine Disruptors - toxicity | Leydig Cells - secretion | Animals | Dogs | HEK293 Cells | ATP-Binding Cassette Transporters - metabolism | Blood-Testis Barrier - drug effects | Mice | Index Medicus
Endocrine disrupting chemicals (EDCs) | ABC transporters | Steroidogenesis | Blood-testis barrier | MA-10 mouse Leydig cells | steroidogenesis | TETRABROMOBISPHENOL-A | RATS | IDENTIFICATION | P-GLYCOPROTEIN | endocrine disrupting chemicals (EDCs) | INHIBITION | EFFLUX | blood-testis barrier | BROMINATED FLAME RETARDANTS | BISPHENOL-A | TOXICOLOGY | EXPRESSION | XENOGRAFTS | Testosterone - secretion | Humans | Cells, Cultured | Male | Leydig Cells - drug effects | Endocrine Disruptors - toxicity | Leydig Cells - secretion | Animals | Dogs | HEK293 Cells | ATP-Binding Cassette Transporters - metabolism | Blood-Testis Barrier - drug effects | Mice | Index Medicus
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 09/2013, Volume 33, Issue 9, pp. 2202 - 2211
OBJECTIVE—The ability of high-density lipoprotein (HDL) to remove cholesterol from atherosclerotic plaque is thought to underlie its inverse correlation with...
high-density lipoproteins, pre-ß | cholesterol | apolipoproteins | acute coronary syndrome | inflammation | REGRESSION | LECITHINCHOLESTEROL ACYLTRANSFERASE | CELLULAR CHOLESTEROL | HUMAN ATHEROSCLEROTIC PLAQUE | high-density lipoproteins, pre-beta | INTRAVENOUS-INFUSION | TRANSPORT | PERIPHERAL VASCULAR DISEASE | MICE | HEMATOLOGY | A-I | LECITHIN | Apolipoprotein A-I - pharmacology | Lipoproteins, HDL - pharmacokinetics | Up-Regulation | Anticholesteremic Agents - blood | Lipoproteins, HDL - blood | Cholesterol - blood | Humans | Cholesterol Esters - blood | Apolipoprotein A-I - pharmacokinetics | Lipoproteins, HDL - pharmacology | Biological Transport | Female | ATP Binding Cassette Transporter 1 | Macrophages - immunology | Cytokines - blood | Cell Line | Lipoproteins, HDL - administration & dosage | Rabbits | Anti-Inflammatory Agents - pharmacology | Inflammation Mediators - blood | Particle Size | Anticholesteremic Agents - pharmacokinetics | Macrophages - metabolism | Animals | ATP-Binding Cassette Transporters - drug effects | Anticholesteremic Agents - administration & dosage | ATP-Binding Cassette Transporters - blood | Cholesterol, HDL - blood | Macrophages - drug effects | Apolipoprotein A-I - administration & dosage | Mice | Infusions, Intravenous | Anticholesteremic Agents - pharmacology | Apolipoprotein A-I - blood
high-density lipoproteins, pre-ß | cholesterol | apolipoproteins | acute coronary syndrome | inflammation | REGRESSION | LECITHINCHOLESTEROL ACYLTRANSFERASE | CELLULAR CHOLESTEROL | HUMAN ATHEROSCLEROTIC PLAQUE | high-density lipoproteins, pre-beta | INTRAVENOUS-INFUSION | TRANSPORT | PERIPHERAL VASCULAR DISEASE | MICE | HEMATOLOGY | A-I | LECITHIN | Apolipoprotein A-I - pharmacology | Lipoproteins, HDL - pharmacokinetics | Up-Regulation | Anticholesteremic Agents - blood | Lipoproteins, HDL - blood | Cholesterol - blood | Humans | Cholesterol Esters - blood | Apolipoprotein A-I - pharmacokinetics | Lipoproteins, HDL - pharmacology | Biological Transport | Female | ATP Binding Cassette Transporter 1 | Macrophages - immunology | Cytokines - blood | Cell Line | Lipoproteins, HDL - administration & dosage | Rabbits | Anti-Inflammatory Agents - pharmacology | Inflammation Mediators - blood | Particle Size | Anticholesteremic Agents - pharmacokinetics | Macrophages - metabolism | Animals | ATP-Binding Cassette Transporters - drug effects | Anticholesteremic Agents - administration & dosage | ATP-Binding Cassette Transporters - blood | Cholesterol, HDL - blood | Macrophages - drug effects | Apolipoprotein A-I - administration & dosage | Mice | Infusions, Intravenous | Anticholesteremic Agents - pharmacology | Apolipoprotein A-I - blood
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2013, Volume 8, Issue 1, p. e53391
textabstractAttempts to develop an efficient anti-staphylococcal vaccine in humans have so far been unsuccessful. Therefore, more knowledge of the antigens...
HETEROGENEITY | METHICILLIN RESISTANCE | GAMMA-HEMOLYSIN | RISK-FACTORS | PROTEIN | LEUKOCIDIN | SUPERANTIGENS | MULTIDISCIPLINARY SCIENCES | STREAM INFECTIONS | ENDOCARDITIS | ANTIBODY-RESPONSES | Bacteremia - immunology | Immunoglobulin G - blood | Humans | Middle Aged | Antigens, Bacterial - immunology | Male | Gene Expression Profiling | Antigens, Bacterial - blood | Phylogeny | Bacteremia - microbiology | ATP-Binding Cassette Transporters - genetics | Immunity, Humoral | Immunoglobulin G - immunology | Bacteremia - blood | Female | Bacterial Proteins - immunology | Staphylococcal Infections - microbiology | Antibodies, Bacterial - blood | Genome, Bacterial - immunology | Staphylococcal Infections - blood | Staphylococcus aureus - genetics | Gene Expression | Staphylococcal Infections - immunology | Staphylococcus aureus - isolation & purification | Bacterial Proteins - genetics | Bacterial Proteins - blood | Staphylococcus aureus - classification | Immunoglobulin A - immunology | ATP-Binding Cassette Transporters - blood | Immunoglobulin A - blood | Antibodies, Bacterial - immunology | Staphylococcus aureus - immunology | Aged | ATP-Binding Cassette Transporters - immunology | Antigens | Medical research | Analysis | Genes | Immunoglobulin G | Medicine, Experimental | Genetic aspects | Vaccines | Bacterial genetics | Gene expression | Bacteremia | Staphylococcus aureus | Flow cytometry | Virulence | Antibodies | Iron | Immunoglobulin A | Blood | Proteins | Virulence factors | Immune system | Immune response | Incubation | Staphylococcus infections | Patients | Immune response (humoral) | Studies | Cytometry | Infectious diseases | DNA microarrays | Immunogenicity | Proteomics | Transporter | ABC transporter
HETEROGENEITY | METHICILLIN RESISTANCE | GAMMA-HEMOLYSIN | RISK-FACTORS | PROTEIN | LEUKOCIDIN | SUPERANTIGENS | MULTIDISCIPLINARY SCIENCES | STREAM INFECTIONS | ENDOCARDITIS | ANTIBODY-RESPONSES | Bacteremia - immunology | Immunoglobulin G - blood | Humans | Middle Aged | Antigens, Bacterial - immunology | Male | Gene Expression Profiling | Antigens, Bacterial - blood | Phylogeny | Bacteremia - microbiology | ATP-Binding Cassette Transporters - genetics | Immunity, Humoral | Immunoglobulin G - immunology | Bacteremia - blood | Female | Bacterial Proteins - immunology | Staphylococcal Infections - microbiology | Antibodies, Bacterial - blood | Genome, Bacterial - immunology | Staphylococcal Infections - blood | Staphylococcus aureus - genetics | Gene Expression | Staphylococcal Infections - immunology | Staphylococcus aureus - isolation & purification | Bacterial Proteins - genetics | Bacterial Proteins - blood | Staphylococcus aureus - classification | Immunoglobulin A - immunology | ATP-Binding Cassette Transporters - blood | Immunoglobulin A - blood | Antibodies, Bacterial - immunology | Staphylococcus aureus - immunology | Aged | ATP-Binding Cassette Transporters - immunology | Antigens | Medical research | Analysis | Genes | Immunoglobulin G | Medicine, Experimental | Genetic aspects | Vaccines | Bacterial genetics | Gene expression | Bacteremia | Staphylococcus aureus | Flow cytometry | Virulence | Antibodies | Iron | Immunoglobulin A | Blood | Proteins | Virulence factors | Immune system | Immune response | Incubation | Staphylococcus infections | Patients | Immune response (humoral) | Studies | Cytometry | Infectious diseases | DNA microarrays | Immunogenicity | Proteomics | Transporter | ABC transporter
Journal Article
MEDICAL SCIENCE MONITOR, ISSN 1643-3750, 12/2017, Volume 23, pp. 5851 - 5861
Background: ABCA2 has been genetically linked to Alzheimer's disease (AD) risk, but its mRNA expression and epigenetics in AD have not been investigated....
MEDICINE, RESEARCH & EXPERIMENTAL | TRIALS | HUMAN BRAIN | CHOLESTEROL | TRANSPORTERS | TISSUE | Gene Expression Profiling | Alzheimer Disease | BIOMARKERS | ATP-Binding Cassette Transporters | EFFLUX | GENE | NEUROPATHOLOGY | Methylation | Up-Regulation | Genetic Predisposition to Disease | Cognitive Dysfunction - metabolism | Epigenesis, Genetic | Humans | RNA, Messenger - genetics | Databases, Genetic | Huntington Disease - metabolism | Tissue Array Analysis - methods | ATP-Binding Cassette Transporters - biosynthesis | Alzheimer Disease - diagnosis | RNA, Messenger - biosynthesis | Amyloid beta-Protein Precursor - genetics | RNA, Messenger - blood | ATP-Binding Cassette Transporters - genetics | ATP-Binding Cassette Transporters - blood | Alzheimer Disease - metabolism | ATP-Binding Cassette Transporters - metabolism | CpG Islands | Huntington Disease - genetics | Cognitive Dysfunction - genetics | Alzheimer Disease - genetics | Alzheimer Disease - blood
MEDICINE, RESEARCH & EXPERIMENTAL | TRIALS | HUMAN BRAIN | CHOLESTEROL | TRANSPORTERS | TISSUE | Gene Expression Profiling | Alzheimer Disease | BIOMARKERS | ATP-Binding Cassette Transporters | EFFLUX | GENE | NEUROPATHOLOGY | Methylation | Up-Regulation | Genetic Predisposition to Disease | Cognitive Dysfunction - metabolism | Epigenesis, Genetic | Humans | RNA, Messenger - genetics | Databases, Genetic | Huntington Disease - metabolism | Tissue Array Analysis - methods | ATP-Binding Cassette Transporters - biosynthesis | Alzheimer Disease - diagnosis | RNA, Messenger - biosynthesis | Amyloid beta-Protein Precursor - genetics | RNA, Messenger - blood | ATP-Binding Cassette Transporters - genetics | ATP-Binding Cassette Transporters - blood | Alzheimer Disease - metabolism | ATP-Binding Cassette Transporters - metabolism | CpG Islands | Huntington Disease - genetics | Cognitive Dysfunction - genetics | Alzheimer Disease - genetics | Alzheimer Disease - blood
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 63, Issue 20, pp. 2121 - 2128
Objectives The study sought to test the hypothesis that genetic variation in ABCG5/8 , the transporter responsible for intestinal and hepatobiliary cholesterol...
Cardiovascular | Internal Medicine | ABCG8 | cholesterol | myocardial infarction | ABCG5 | gallstones | myocardial infarction | CARDIAC & CARDIOVASCULAR SYSTEMS | MENDELIAN RANDOMIZATION | HYPERCHOLESTEROLEMIA | POLYMORPHISM | DENSITY-LIPOPROTEIN CHOLESTEROL | CAUSAL RISK-FACTOR | CARDIOVASCULAR-DISEASE | MICE | ABSORPTION | SECRETION | ASSOCIATION | Myocardial Infarction - blood | Myocardial Infarction - genetics | Myocardial Infarction - epidemiology | Prevalence | Lipoproteins - genetics | Humans | Middle Aged | Gallstones - epidemiology | Genotype | Male | Lipoproteins - blood | Gallstones - blood | Genetic Variation | Gallstones - genetics | ATP-Binding Cassette Transporters - genetics | ATP-Binding Cassette Transporters - blood | Denmark - epidemiology | Female | ATP Binding Cassette Transporter, Sub-Family G, Member 8 | Aged | ATP Binding Cassette Transporter, Sub-Family G, Member 5 | Gallstones | Sects | Analysis | Cholesterol | Heart attack | Low density lipoproteins | Risk factors | Hormone replacement therapy | Heart attacks | Low density lipoprotein
Cardiovascular | Internal Medicine | ABCG8 | cholesterol | myocardial infarction | ABCG5 | gallstones | myocardial infarction | CARDIAC & CARDIOVASCULAR SYSTEMS | MENDELIAN RANDOMIZATION | HYPERCHOLESTEROLEMIA | POLYMORPHISM | DENSITY-LIPOPROTEIN CHOLESTEROL | CAUSAL RISK-FACTOR | CARDIOVASCULAR-DISEASE | MICE | ABSORPTION | SECRETION | ASSOCIATION | Myocardial Infarction - blood | Myocardial Infarction - genetics | Myocardial Infarction - epidemiology | Prevalence | Lipoproteins - genetics | Humans | Middle Aged | Gallstones - epidemiology | Genotype | Male | Lipoproteins - blood | Gallstones - blood | Genetic Variation | Gallstones - genetics | ATP-Binding Cassette Transporters - genetics | ATP-Binding Cassette Transporters - blood | Denmark - epidemiology | Female | ATP Binding Cassette Transporter, Sub-Family G, Member 8 | Aged | ATP Binding Cassette Transporter, Sub-Family G, Member 5 | Gallstones | Sects | Analysis | Cholesterol | Heart attack | Low density lipoproteins | Risk factors | Hormone replacement therapy | Heart attacks | Low density lipoprotein
Journal Article
Stroke, ISSN 0039-2499, 03/2015, Volume 46, Issue 3, pp. 827 - 834
BACKGROUND AND PURPOSE—The ATP-binding cassette transporter A-1 (ABCA1) gene is a key target of the transcription factors liver X receptors. Liver X receptor...
Aquaporin 4 | Stroke | Insulin-like growth factor binding protein 1 | Blood-brain barrier | White matter | ATP binding cassette transporter A-1 | blood-brain barrier | ABCA1 | SYSTEM | INJURY | stroke | CLINICAL NEUROLOGY | white matter | insulin-like growth factor binding protein 1 | NEUROINFLAMMATION | INTEGRITY | aquaporin 4 | DISEASE | AQUAPORIN-4 | PERIPHERAL VASCULAR DISEASE | CEREBRAL-ISCHEMIA | EXPRESSION | PERICYTES | Astrocytes - cytology | Immunohistochemistry | Cells, Cultured | Male | Mice, Transgenic | Treatment Outcome | Infarction, Middle Cerebral Artery - pathology | Stroke - genetics | Mice, Knockout | White Matter - pathology | Stroke - blood | Blood-Brain Barrier - pathology | Matrix Metalloproteinase 9 - metabolism | Animals | ATP Binding Cassette Transporter 1 - physiology | Mice | Brain Injuries - pathology | Insulin-Like Growth Factor I - metabolism | ATP Binding Cassette Transporter 1 - genetics | Disease Models, Animal
Aquaporin 4 | Stroke | Insulin-like growth factor binding protein 1 | Blood-brain barrier | White matter | ATP binding cassette transporter A-1 | blood-brain barrier | ABCA1 | SYSTEM | INJURY | stroke | CLINICAL NEUROLOGY | white matter | insulin-like growth factor binding protein 1 | NEUROINFLAMMATION | INTEGRITY | aquaporin 4 | DISEASE | AQUAPORIN-4 | PERIPHERAL VASCULAR DISEASE | CEREBRAL-ISCHEMIA | EXPRESSION | PERICYTES | Astrocytes - cytology | Immunohistochemistry | Cells, Cultured | Male | Mice, Transgenic | Treatment Outcome | Infarction, Middle Cerebral Artery - pathology | Stroke - genetics | Mice, Knockout | White Matter - pathology | Stroke - blood | Blood-Brain Barrier - pathology | Matrix Metalloproteinase 9 - metabolism | Animals | ATP Binding Cassette Transporter 1 - physiology | Mice | Brain Injuries - pathology | Insulin-Like Growth Factor I - metabolism | ATP Binding Cassette Transporter 1 - genetics | Disease Models, Animal
Journal Article
Drug Metabolism and Disposition, ISSN 0090-9556, 06/2010, Volume 38, Issue 6, pp. 917 - 922
[C-11] N-desmethyl-Loperamide ([C-11]dLop) is used in positron emission tomography (PET) to measure the in vivo activity of efflux transporters that block the...
CELLS | INHIBITION | DISEASES | SUBSTRATE | PHARMACOLOGY & PHARMACY | MULTIDRUG-RESISTANCE | CANCER | TARIQUIDAR | XR9576 | DRUG EFFLUX TRANSPORTERS | REVERSAL | Tissue Distribution - physiology | Radiopharmaceuticals - pharmacokinetics | Humans | Glycoproteins - metabolism | Loperamide - pharmacology | Cerebrovascular Circulation | Loperamide - analogs & derivatives | Blood-Brain Barrier - metabolism | Brain - metabolism | Anti-HIV Agents - chemistry | ATP Binding Cassette Transporter, Subfamily B, Member 1 | Animals | Loperamide - pharmacokinetics | Anti-HIV Agents - pharmacokinetics | ATP-Binding Cassette Transporters - metabolism | Biological Transport - physiology | Mice | Tumor Cells, Cultured | Loperamide - chemistry | Multidrug Resistance-Associated Proteins
CELLS | INHIBITION | DISEASES | SUBSTRATE | PHARMACOLOGY & PHARMACY | MULTIDRUG-RESISTANCE | CANCER | TARIQUIDAR | XR9576 | DRUG EFFLUX TRANSPORTERS | REVERSAL | Tissue Distribution - physiology | Radiopharmaceuticals - pharmacokinetics | Humans | Glycoproteins - metabolism | Loperamide - pharmacology | Cerebrovascular Circulation | Loperamide - analogs & derivatives | Blood-Brain Barrier - metabolism | Brain - metabolism | Anti-HIV Agents - chemistry | ATP Binding Cassette Transporter, Subfamily B, Member 1 | Animals | Loperamide - pharmacokinetics | Anti-HIV Agents - pharmacokinetics | ATP-Binding Cassette Transporters - metabolism | Biological Transport - physiology | Mice | Tumor Cells, Cultured | Loperamide - chemistry | Multidrug Resistance-Associated Proteins
Journal Article
FASEB Journal, ISSN 0892-6638, 10/2012, Volume 26, Issue 10, pp. 4014 - 4024
ABCG2 is an ATP-dependent efflux transporter that limits the systemic exposure of its substrates. The preferred substrates of ABCG2 in vivo are largely...
BCRP | Metabolomics | Phase II metabolism | Vesicular transport | GLUCURONIDE | BIOCHEMISTRY & MOLECULAR BIOLOGY | GENISTEIN | EXCRETION | DISPOSITION | phase II metabolism | CELL BIOLOGY | METABOLISM | ACETAMINOPHEN | metabolomics | BIOLOGY | INFERTILITY | EXPRESSION | vesicular transport | ATP Binding Cassette Transporter, Sub-Family G, Member 2 | Membrane Transport Proteins - blood | Male | Membrane Transport Proteins - urine | Chromatography, High Pressure Liquid | Mice, Knockout | Animals | ATP-Binding Cassette Transporters - genetics | Membrane Transport Proteins - genetics | Mass Spectrometry | ATP-Binding Cassette Transporters - blood | ATP-Binding Cassette Transporters - metabolism | Female | Membrane Transport Proteins - metabolism | Phytoestrogens - metabolism | Biological Transport - genetics | Biological Transport - physiology | Mice | ATP-Binding Cassette Transporters - urine
BCRP | Metabolomics | Phase II metabolism | Vesicular transport | GLUCURONIDE | BIOCHEMISTRY & MOLECULAR BIOLOGY | GENISTEIN | EXCRETION | DISPOSITION | phase II metabolism | CELL BIOLOGY | METABOLISM | ACETAMINOPHEN | metabolomics | BIOLOGY | INFERTILITY | EXPRESSION | vesicular transport | ATP Binding Cassette Transporter, Sub-Family G, Member 2 | Membrane Transport Proteins - blood | Male | Membrane Transport Proteins - urine | Chromatography, High Pressure Liquid | Mice, Knockout | Animals | ATP-Binding Cassette Transporters - genetics | Membrane Transport Proteins - genetics | Mass Spectrometry | ATP-Binding Cassette Transporters - blood | ATP-Binding Cassette Transporters - metabolism | Female | Membrane Transport Proteins - metabolism | Phytoestrogens - metabolism | Biological Transport - genetics | Biological Transport - physiology | Mice | ATP-Binding Cassette Transporters - urine
Journal Article
JAMA, ISSN 0098-7484, 04/2010, Volume 303, Issue 13, pp. 1266 - 1273
CONTEXT Novel therapies have improved the remission rate in chronic inflammatory disorders including juvenile idiopathic arthritis (JIA). Therefore, strategies...
RHEUMATOID-ARTHRITIS | CRITERIA | THERAPY | PROTEINS 8 | INFLAMMATION | VALIDATION | SELECT CATEGORIES | UMCG Approved | DISCONTINUATION | DISEASE-ACTIVITY | CHILDREN | MEDICINE, GENERAL & INTERNAL | Predictive Value of Tests | Recurrence | Calgranulin B - blood | Prospective Studies | Antirheumatic Agents - administration & dosage | Humans | Child, Preschool | Infant | Male | Remission Induction | Arthritis, Juvenile - drug therapy | ATP-Binding Cassette Transporters - blood | Adolescent | Female | Methotrexate - administration & dosage | Child | Clinical trials | Biomarkers | Patient safety | Arthritis | Drug therapy | Risk factors
RHEUMATOID-ARTHRITIS | CRITERIA | THERAPY | PROTEINS 8 | INFLAMMATION | VALIDATION | SELECT CATEGORIES | UMCG Approved | DISCONTINUATION | DISEASE-ACTIVITY | CHILDREN | MEDICINE, GENERAL & INTERNAL | Predictive Value of Tests | Recurrence | Calgranulin B - blood | Prospective Studies | Antirheumatic Agents - administration & dosage | Humans | Child, Preschool | Infant | Male | Remission Induction | Arthritis, Juvenile - drug therapy | ATP-Binding Cassette Transporters - blood | Adolescent | Female | Methotrexate - administration & dosage | Child | Clinical trials | Biomarkers | Patient safety | Arthritis | Drug therapy | Risk factors
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 02/2009, Volume 29, Issue 2, pp. 261 - 267
OBJECTIVE—The purpose of this study was to examine the interactive action of serum amyloid A (SAA), group IIA secretory phospholipase A2 (sPLA2-IIA), and...
CETP | HDL | SAA | Inflammation | apoA-I | ESTER TRANSFER PROTEIN | SIZE | SERUM-AMYLOID-A | SECRETORY PHOSPHOLIPASE A | HIGH-DENSITY-LIPOPROTEIN | ANTIINFLAMMATORY PROPERTIES | PLASMA | MESSENGER-RNA | METABOLISM | inflammation | REVERSE CHOLESTEROL TRANSPORT | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | Recombinant Proteins - metabolism | ATP Binding Cassette Transporter, Sub-Family G, Member 1 | Serum Amyloid A Protein - metabolism | Lipoproteins, HDL - blood | Cholesterol - blood | Humans | Cardiac Surgical Procedures - adverse effects | Group II Phospholipases A2 - blood | Cholesterol Ester Transfer Proteins - blood | Macrophages - metabolism | Chromatography, Affinity | Time Factors | ATP-Binding Cassette Transporters - blood | Acute-Phase Reaction - blood | ATP Binding Cassette Transporter 1 | Acute-Phase Reaction - etiology | Apolipoprotein A-I - blood
CETP | HDL | SAA | Inflammation | apoA-I | ESTER TRANSFER PROTEIN | SIZE | SERUM-AMYLOID-A | SECRETORY PHOSPHOLIPASE A | HIGH-DENSITY-LIPOPROTEIN | ANTIINFLAMMATORY PROPERTIES | PLASMA | MESSENGER-RNA | METABOLISM | inflammation | REVERSE CHOLESTEROL TRANSPORT | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | Recombinant Proteins - metabolism | ATP Binding Cassette Transporter, Sub-Family G, Member 1 | Serum Amyloid A Protein - metabolism | Lipoproteins, HDL - blood | Cholesterol - blood | Humans | Cardiac Surgical Procedures - adverse effects | Group II Phospholipases A2 - blood | Cholesterol Ester Transfer Proteins - blood | Macrophages - metabolism | Chromatography, Affinity | Time Factors | ATP-Binding Cassette Transporters - blood | Acute-Phase Reaction - blood | ATP Binding Cassette Transporter 1 | Acute-Phase Reaction - etiology | Apolipoprotein A-I - blood
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2014, Volume 9, Issue 9, pp. e95452 - e95452
Chlorogenic acid (CGA) is one of the most abundant polyphenols in the human diet and is suggested to be a potential antiatherosclerotic agent due to its...
ACTIVATION | FOAM CELL-FORMATION | CAFFEIC ACID | PATHWAY | GLUCOSE | MULTIDISCIPLINARY SCIENCES | CARDIOVASCULAR-DISEASE | GENE-EXPRESSION | RATS | COFFEE CONSUMPTION | RECEPTOR-ALPHA | ATP Binding Cassette Transporter, Sub-Family G, Member 1 | Apolipoproteins E - deficiency | Atorvastatin Calcium - pharmacology | Chlorogenic Acid - pharmacology | Lipoproteins - genetics | Cholesterol - blood | Diet, High-Fat - adverse effects | Atherosclerosis - etiology | Caffeic Acids - isolation & purification | ATP-Binding Cassette Transporters - genetics | Liver X Receptors | Cholesterol, LDL - blood | Biological Transport - drug effects | Plaque, Atherosclerotic - blood | Plaque, Atherosclerotic - pathology | PPAR gamma - genetics | Gallic Acid - isolation & purification | Cell Line | Atherosclerosis - pathology | Gene Expression | Atherosclerosis - drug therapy | Macrophages - pathology | Aorta - drug effects | ATP Binding Cassette Transporter 1 - blood | Lipoproteins - blood | Orphan Nuclear Receptors - genetics | Mice, Knockout | Plaque, Atherosclerotic - etiology | Atherosclerosis - blood | Orphan Nuclear Receptors - blood | Macrophages - metabolism | Animals | Lipoproteins, LDL - antagonists & inhibitors | Apolipoproteins E - genetics | Coumaric Acids - isolation & purification | ATP-Binding Cassette Transporters - blood | Triglycerides - blood | Macrophages - drug effects | Mice | Plaque, Atherosclerotic - drug therapy | Vasodilation - drug effects | Chlorogenic Acid - chemistry | PPAR gamma - blood | Anticholesteremic Agents - pharmacology | Cholesterol - adverse effects | Lipoproteins, LDL - blood | ATP Binding Cassette Transporter 1 - genetics | Oxidative stress | Transcription | Glucose | Macrophages | Coffee | ABCA1 protein | Toxicology | Ultrasonic imaging | Metabolites | Apolipoprotein E | Rodents | Atherosclerosis | Polyphenols | Aorta | Supplementation | Stretching | Food | Efflux | Dietary supplements | Chlorogenic acid | Triglycerides | Pharmacology | Inflammation | Gene expression | Cholesterol | Herbal medicine | Acids | Diet | Arteriosclerosis | Coronary vessels | Atorvastatin | ATP-binding protein | Plasma levels | Laboratory animals | Index Medicus
ACTIVATION | FOAM CELL-FORMATION | CAFFEIC ACID | PATHWAY | GLUCOSE | MULTIDISCIPLINARY SCIENCES | CARDIOVASCULAR-DISEASE | GENE-EXPRESSION | RATS | COFFEE CONSUMPTION | RECEPTOR-ALPHA | ATP Binding Cassette Transporter, Sub-Family G, Member 1 | Apolipoproteins E - deficiency | Atorvastatin Calcium - pharmacology | Chlorogenic Acid - pharmacology | Lipoproteins - genetics | Cholesterol - blood | Diet, High-Fat - adverse effects | Atherosclerosis - etiology | Caffeic Acids - isolation & purification | ATP-Binding Cassette Transporters - genetics | Liver X Receptors | Cholesterol, LDL - blood | Biological Transport - drug effects | Plaque, Atherosclerotic - blood | Plaque, Atherosclerotic - pathology | PPAR gamma - genetics | Gallic Acid - isolation & purification | Cell Line | Atherosclerosis - pathology | Gene Expression | Atherosclerosis - drug therapy | Macrophages - pathology | Aorta - drug effects | ATP Binding Cassette Transporter 1 - blood | Lipoproteins - blood | Orphan Nuclear Receptors - genetics | Mice, Knockout | Plaque, Atherosclerotic - etiology | Atherosclerosis - blood | Orphan Nuclear Receptors - blood | Macrophages - metabolism | Animals | Lipoproteins, LDL - antagonists & inhibitors | Apolipoproteins E - genetics | Coumaric Acids - isolation & purification | ATP-Binding Cassette Transporters - blood | Triglycerides - blood | Macrophages - drug effects | Mice | Plaque, Atherosclerotic - drug therapy | Vasodilation - drug effects | Chlorogenic Acid - chemistry | PPAR gamma - blood | Anticholesteremic Agents - pharmacology | Cholesterol - adverse effects | Lipoproteins, LDL - blood | ATP Binding Cassette Transporter 1 - genetics | Oxidative stress | Transcription | Glucose | Macrophages | Coffee | ABCA1 protein | Toxicology | Ultrasonic imaging | Metabolites | Apolipoprotein E | Rodents | Atherosclerosis | Polyphenols | Aorta | Supplementation | Stretching | Food | Efflux | Dietary supplements | Chlorogenic acid | Triglycerides | Pharmacology | Inflammation | Gene expression | Cholesterol | Herbal medicine | Acids | Diet | Arteriosclerosis | Coronary vessels | Atorvastatin | ATP-binding protein | Plasma levels | Laboratory animals | Index Medicus
Journal Article
Annals of the rheumatic diseases, ISSN 0003-4967, 2015, Volume 74, Issue 3, pp. 499 - 505
Background One-third of rheumatoid arthritis (RA) patients treated with biological therapy show lack of response. The use of predictive biomarkers to identify...
C-REACTIVE PROTEIN | BIOMARKERS | SYNOVIAL TISSUE | RITUXIMAB | JUVENILE IDIOPATHIC ARTHRITIS | RECEPTOR | MONOCLONAL-ANTIBODY | RHEUMATOLOGY | ANTITUMOR NECROSIS FACTOR | S100 PROTEINS | DISEASE-ACTIVITY | Antibodies, Monoclonal, Humanized - therapeutic use | Calgranulin B - blood | Prognosis | Prospective Studies | Arthritis, Rheumatoid - blood | Humans | Middle Aged | Rituximab | Antibodies, Monoclonal - therapeutic use | Male | Treatment Outcome | Biomarkers - blood | Infliximab | Arthritis, Rheumatoid - drug therapy | ATP-Binding Cassette Transporters - blood | Adult | Female | Adalimumab | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Antirheumatic Agents - therapeutic use | Cohort Studies | Care and treatment | Usage | Biological products | Rheumatoid arthritis | Analysis | Serum | Risk factors
C-REACTIVE PROTEIN | BIOMARKERS | SYNOVIAL TISSUE | RITUXIMAB | JUVENILE IDIOPATHIC ARTHRITIS | RECEPTOR | MONOCLONAL-ANTIBODY | RHEUMATOLOGY | ANTITUMOR NECROSIS FACTOR | S100 PROTEINS | DISEASE-ACTIVITY | Antibodies, Monoclonal, Humanized - therapeutic use | Calgranulin B - blood | Prognosis | Prospective Studies | Arthritis, Rheumatoid - blood | Humans | Middle Aged | Rituximab | Antibodies, Monoclonal - therapeutic use | Male | Treatment Outcome | Biomarkers - blood | Infliximab | Arthritis, Rheumatoid - drug therapy | ATP-Binding Cassette Transporters - blood | Adult | Female | Adalimumab | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Antirheumatic Agents - therapeutic use | Cohort Studies | Care and treatment | Usage | Biological products | Rheumatoid arthritis | Analysis | Serum | Risk factors
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2014, Volume 9, Issue 5, p. e97646
Objective: Uric acid is the end product of purine metabolism in humans, and increased serum uric acid concentrations lead to gout. The objective of the current...
METHYLENETETRAHYDROFOLATE REDUCTASE | SLC2A9 | RENAL HYPOURICEMIA | ABCG2 GENE | RISK-FACTORS | HYPERURICEMIA | GOUT | MULTIDISCIPLINARY SCIENCES | TETRAHYDROFOLATE REDUCTASE GENE | POLYMORPHISM | URATE TRANSPORTER | ATP Binding Cassette Transporter, Sub-Family G, Member 2 | Glucose Transport Proteins, Facilitative - blood | Humans | Middle Aged | Male | Metabolic Syndrome - blood | ATP-Binding Cassette Transporters - genetics | Methylenetetrahydrofolate Reductase (NADPH2) - genetics | Methylenetetrahydrofolate Reductase (NADPH2) - blood | Adult | Female | Uric Acid - blood | Glucose Transport Proteins, Facilitative - genetics | Neoplasm Proteins - genetics | Gene Expression | Alcohol Drinking - pathology | Alcohol Drinking - genetics | Regression Analysis | Alcohol Drinking - blood | Metabolic Syndrome - genetics | ATP-Binding Cassette Transporters - blood | Adolescent | Sex Factors | Neoplasm Proteins - blood | Aged | Models, Genetic | Polymorphism, Single Nucleotide | Metabolic Syndrome - pathology | Cohort Studies | Genetic research | Physiological aspects | Genetic aspects | Drinking of alcoholic beverages | Uric acid | Wine | Disease | Control methods | Anthropometry | Genes | Gout | Alcohol | Genomes | Arthritis | Methylenetetrahydrofolate reductase | Criteria | Metabolic syndrome | Alcohols | Demographic variables | Body mass index | Demographics | Regression models | Rheumatism | ABCG gene | Genetic factors | Hypertension | Enzymes | Adenosine | Drinking behavior | Regression analysis | Metabolism | Medicine | Studies | Genetic variance | Hospitals | Acids | Mutation | Transporter | Metabolic disorders
METHYLENETETRAHYDROFOLATE REDUCTASE | SLC2A9 | RENAL HYPOURICEMIA | ABCG2 GENE | RISK-FACTORS | HYPERURICEMIA | GOUT | MULTIDISCIPLINARY SCIENCES | TETRAHYDROFOLATE REDUCTASE GENE | POLYMORPHISM | URATE TRANSPORTER | ATP Binding Cassette Transporter, Sub-Family G, Member 2 | Glucose Transport Proteins, Facilitative - blood | Humans | Middle Aged | Male | Metabolic Syndrome - blood | ATP-Binding Cassette Transporters - genetics | Methylenetetrahydrofolate Reductase (NADPH2) - genetics | Methylenetetrahydrofolate Reductase (NADPH2) - blood | Adult | Female | Uric Acid - blood | Glucose Transport Proteins, Facilitative - genetics | Neoplasm Proteins - genetics | Gene Expression | Alcohol Drinking - pathology | Alcohol Drinking - genetics | Regression Analysis | Alcohol Drinking - blood | Metabolic Syndrome - genetics | ATP-Binding Cassette Transporters - blood | Adolescent | Sex Factors | Neoplasm Proteins - blood | Aged | Models, Genetic | Polymorphism, Single Nucleotide | Metabolic Syndrome - pathology | Cohort Studies | Genetic research | Physiological aspects | Genetic aspects | Drinking of alcoholic beverages | Uric acid | Wine | Disease | Control methods | Anthropometry | Genes | Gout | Alcohol | Genomes | Arthritis | Methylenetetrahydrofolate reductase | Criteria | Metabolic syndrome | Alcohols | Demographic variables | Body mass index | Demographics | Regression models | Rheumatism | ABCG gene | Genetic factors | Hypertension | Enzymes | Adenosine | Drinking behavior | Regression analysis | Metabolism | Medicine | Studies | Genetic variance | Hospitals | Acids | Mutation | Transporter | Metabolic disorders
Journal Article